etofibrate has been researched along with Elevated Cholesterol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bochenek, W; Słowińska, R; Unlot, J | 1 |
| Mertz, DP | 1 |
| Catalán, RE; Maroto, ML; Piña, M; Priego, JG | 1 |
| Rahlfs, VW; Safer, A; Zimmermann, H | 1 |
| Burkard, M; Huth, K; Quack, G; Richter, CM; Wülfroth, P | 1 |
| Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A | 1 |
| Caslake, MJ; Cruickshank, A; Demant, T; Kilday, C; Packard, CJ; Series, JJ; Shepherd, J | 1 |
2 trial(s) available for etofibrate and Elevated Cholesterol
| Article | Year |
|---|---|
[Study of the antilipemic effect of etofibrate (Lipo-Merz)].
Topics: Adult; Aged; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged | 1983 |
[Etofibrate and clofibrate in double blind study].
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Nicotinic Acids; Placebos | 1976 |
5 other study(ies) available for etofibrate and Elevated Cholesterol
| Article | Year |
|---|---|
[Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate].
Topics: Adult; Bezafibrate; Clofibrate; Clofibric Acid; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged | 1980 |
Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
Topics: Animals; Clofibrate; Clofibric Acid; Diet; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Liver; Male; Nicotinic Acids; Rats; Triglycerides | 1979 |
Etofibrate treatment alters low density lipoprotein susceptibility to lipid peroxidation.
Topics: Animals; Cholesterol, Dietary; Cholesterol, LDL; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Peroxidation; Rabbits; Triglycerides | 1992 |
[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
Topics: Adult; Arteriosclerosis Obliterans; Cholesterol, HDL; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Male; Triglycerides | 1989 |
Influence of etofibrate on low density lipoprotein metabolism.
Topics: Adult; Anticholesteremic Agents; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged | 1988 |